Cargando…

Identification of latent tuberculosis infection in rheumatic patients under consideration for treatment with anti-TNF-α agents

INTRODUCTION: Immunosuppressive therapy with anti-tumour necrosis factor-α (TNF-α) agents in rheumatic patients modulates the immune system and may increase the risk of reactivating infections that are normally maintained in a latent state, such as tuberculosis. The purpose of this study was to anal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paluch-Oleś, Jolanta, Magryś, Agnieszka, Kozioł-Montewka, Maria, Koszarny, Arkadiusz, Majdan, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2013
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598128/ https://www.ncbi.nlm.nih.gov/pubmed/23515560 http://dx.doi.org/10.5114/aoms.2013.33352

Ejemplares similares

Sicca syndrome in the same family – the importance of anti-Ro60, anti-Ro52 and anti-La antibody profiling in Sjögren’s syndrome
por: Koszarny, Arkadiusz, et al.
Publicado: (2021)

Prevalence of selected organ-specific autoantibodies in rheumatoid arthritis and primary Sjögren's syndrome patients
por: Koszarny, Arkadiusz, et al.
Publicado: (2015)

Influence of antiphospholipid antibody positivity on glomerular filtration rate markers in a group of systemic sclerosis patients – a 24-month observation
por: Wielosz, Ewa, et al.
Publicado: (2017)

The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infection
por: Atteno, Mariangela, et al.
Publicado: (2014)

Latent tuberculosis infection in patients with rheumatic diseases
por: Anton, Camila, et al.
Publicado: (2019)

Gentamicin-impregnated collagen sponge for preventing sternal wound infection after cardiac surgery
por: Kozioł, Małgorzata, et al.
Publicado: (2014)

Risk of latent tuberculosis in at-risk children with rheumatic diseases
por: Lim, SC, et al.
Publicado: (2011)

IL-35, TNF-α, BAFF, and VEGF serum levels in patients with different rheumatic diseases
por: Wojdasiewicz, Piotr, et al.
Publicado: (2019)

Latent Rheumatism
por: Jessop, Charles Moore
Publicado: (1887)

The Role of TNF-α and Anti-TNF-α Agents during Preconception, Pregnancy, and Breastfeeding
por: Romanowska-Próchnicka, Katarzyna, et al.
Publicado: (2021)

Concurrent peritonsillar abscess and poststreptococcal reactive arthritis complicating acute streptococcal tonsillitis in a young healthy adult: a case report
por: Mazur, Elżbieta, et al.
Publicado: (2015)

Latent Rheumatic Conditions
por: Phelan, J. R.
Publicado: (1906)

Screening for Latent Tuberculosis Infection in Patients with Autoimmune Diseases Before Initiating TNF-α Inhibitors Therapy
por: Perifanou, Dimitra, et al.
Publicado: (2018)

Latent tuberculosis and the use of immunomodulatory agents
por: Aguiar, Fábio Silva, et al.
Publicado: (2019)

Status of etoricoxib in the treatment of rheumatic diseases. Expert panel opinion
por: Kwiatkowska, Brygida, et al.
Publicado: (2017)

Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain
por: Calzada-Hernández, Joan, et al.
Publicado: (2022)

Transmembrane TNF-α: structure, function and interaction with anti-TNF agents
por: Horiuchi, Takahiko, et al.
Publicado: (2010)

Diagnosis and Treatment of Latent Tuberculosis Infection due to Initiation of Anti-TNF Therapy
por: Shim, Tae Sun
Publicado: (2014)

Microbiota: A Missing Link in The Pathogenesis of Chronic Lung Inflammatory Diseases
por: MAGRYŚ, AGNIESZKA
Publicado: (2021)

Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment
por: Happonen, Kaisa E, et al.
Publicado: (2012)

Anti-Rheumatic Effect of Antisense Oligonucleotide Cytos-11 Targeting TNF-α Expression
por: Makalish, Tatyana P., et al.
Publicado: (2021)

Systemic review: agreement between the latent tuberculosis screening tests among patients with rheumatic diseases
por: Pyo, Junhee, et al.
Publicado: (2018)

Tuberculosis in children and adolescents with rheumatic diseases using biologic agents: an integrative review
por: Lima, Lenita de Melo, et al.
Publicado: (2023)

The road to success of coagulase-negative staphylococci: clinical significance of small colony variants and their pathogenic role in persistent infections
por: Bogut, Agnieszka, et al.
Publicado: (2021)

Rheumatism and Tuberculosis
por: Bibb, R. H. L.
Publicado: (1913)

B cell responses in older adults with latent tuberculosis: Considerations for vaccine development
por: Helbig, Sina, et al.
Publicado: (2016)

Effects of anti-TNF-α treatment on lipid profile in rheumatic diseases: an analytical cohort study
por: Hassan, Shadi, et al.
Publicado: (2016)

Chest roentgenography is complementary to interferon-gamma release assay in latent tuberculosis infection screening of rheumatic patients
por: Wang, Ping-Huai, et al.
Publicado: (2020)

HBV Reactivation in Patients Treated with Antitumor Necrosis Factor-Alpha (TNF-α) Agents for Rheumatic and Dermatologic Conditions: A Systematic Review and Meta-Analysis
por: Cantini, Fabrizio, et al.
Publicado: (2014)

Epidemiology, clinical history and microbiology of peritonsillar abscess
por: Mazur, E., et al.
Publicado: (2014)

Neonatal, atopic and infectious disease outcomes among children born to mothers with latent tuberculosis infection
por: Dosanjh, Amrita, et al.
Publicado: (2013)

Incidence of active mycobacterial infections in Brazilian patients with chronic inflammatory arthritis and negative evaluation for latent tuberculosis infection at baseline - A longitudinal analysis after using TNFα blockers
por: Gomes, Carina Mori Frade, et al.
Publicado: (2015)

Postbiotic Fractions of Probiotics Lactobacillus plantarum 299v and Lactobacillus rhamnosus GG Show Immune-Modulating Effects
por: Magryś, Agnieszka, et al.
Publicado: (2023)

The Latent Period Before the Onset of Acute Rheumatic Fever
por: Rammelkamp, Charles H., et al.
Publicado: (1961)

Interferon-Inducible Protein-10 as a Marker to Detect Latent Tuberculosis Infection in Patients with Inflammatory Rheumatic Diseases
por: Ortakoylu, Mediha Gonenc, et al.
Publicado: (2022)

Latent rheumatic, thyroid and phospholipid autoimmunity in hospitalized patients with COVID-19
por: Anaya, Juan-Manuel, et al.
Publicado: (2021)

Can We Predict the Efficacy of Anti-TNF-α Agents?
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2017)

A population-based study of tuberculosis incidence among rheumatic disease patients under anti-TNF treatment
por: Sartori, Natália Sarzi, et al.
Publicado: (2019)

The safety of vedolizumab in a patient with Crohn’s disease who developed anti-TNF-alpha agent associated latent tuberculosis infection reactivation: A case report
por: Sugiyama, Yuya, et al.
Publicado: (2023)

Risk of falls in the rheumatic patient at geriatric age
por: Prusinowska, Agnieszka, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d1a9n4338fdjo2n0cepmn4prln